315 related articles for article (PubMed ID: 25380858)
1. Analysis of the effect of cryoprotectant medium composition to viability of autologous hematopoietic cells collected by leukapheresis.
Kozlowska-Skrzypczak M; Kubiak A; Bembnista E; Matuszak P; Komarnicki M
Transplant Proc; 2014 Oct; 46(8):2535-8. PubMed ID: 25380858
[TBL] [Abstract][Full Text] [Related]
2. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
[TBL] [Abstract][Full Text] [Related]
3. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
[TBL] [Abstract][Full Text] [Related]
4. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.
McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G
Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586
[TBL] [Abstract][Full Text] [Related]
5. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings.
Gokarn A; Tembhare PR; Syed H; Sanyal I; Kumar R; Parab S; Khanka T; Punatar S; Kedia S; Ghogale SG; Deshpande N; Nikam Y; Girase K; Mirgh S; Jindal N; Bagal B; Chichra A; Nayak L; Bonda A; Rath S; Hiregoudar S; Poojary M; Saha S; Ojha S; Subramanian PG; Khattry N
Transplant Cell Ther; 2023 Dec; 29(12):777.e1-777.e8. PubMed ID: 37678607
[TBL] [Abstract][Full Text] [Related]
7. Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium.
Limaye LS; Kale VP
J Hematother Stem Cell Res; 2001 Oct; 10(5):709-18. PubMed ID: 11672518
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation.
Smagur A; Mitrus I; Ciomber A; Panczyniak K; Fidyk W; Sadus-Wojciechowska M; Holowiecki J; Giebel S
Vox Sang; 2015 May; 108(4):417-24. PubMed ID: 25753814
[TBL] [Abstract][Full Text] [Related]
9. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.
Galmés A; Besalduch J; Bargay J; Novo A; Morey M; Guerra JM; Duran MA
Transfusion; 1999 Jan; 39(1):70-3. PubMed ID: 9920169
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques.
Sputtek A; Jetter S; Hummel K; Kühnl P
Beitr Infusionsther Transfusionsmed; 1997; 34():79-83. PubMed ID: 9356660
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.
Dijkstra-Tiekstra MJ; Setroikromo AC; Kraan M; Gkoumassi E; de Wildt-Eggen J
Transfusion; 2014 Dec; 54(12):3155-63. PubMed ID: 25109216
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing.
Galmés A; Besalduch J; Bargay J; Matamoros N; Durán MA; Morey M; Alvarez F; Mascaró M
Transfusion; 1996 Sep; 36(9):794-7. PubMed ID: 8823452
[TBL] [Abstract][Full Text] [Related]
13. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
Lakota J; Fuchsberger P
Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
[No Abstract] [Full Text] [Related]
15. A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant.
Galmés A; Besalduch J; Bargay J; Matamoros N; Morey M; Novo A; Sampol A
Leuk Lymphoma; 1995 Mar; 17(1-2):181-4. PubMed ID: 7773157
[TBL] [Abstract][Full Text] [Related]
16. Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at -80 degrees C in a mechanical freezer.
Galmes A; Gutiérrez A; Sampol A; Canaro M; Morey M; Iglesias J; Matamoros N; Duran MA; Novo A; Bea MD; Galán P; Balansat J; Martínez J; Bargay J; Besalduch J
Haematologica; 2007 Jul; 92(7):986-9. PubMed ID: 17606452
[TBL] [Abstract][Full Text] [Related]
17. Banking of Hematopoietic Stem Cells: Influence of Storage Time on Their Quality Parameters.
Kubiak A; Matuszak P; Bembnista E; Kozlowska-Skrzypczak M
Transplant Proc; 2016 Jun; 48(5):1806-9. PubMed ID: 27496496
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F
Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975
[TBL] [Abstract][Full Text] [Related]
19. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.
Rowley SD; Feng Z; Chen L; Holmberg L; Heimfeld S; MacLeod B; Bensinger WI
Bone Marrow Transplant; 2003 Jun; 31(11):1043-51. PubMed ID: 12774058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
